Hydralazine Hydrochloride Tablet
Product Images NDC 0615-7973

2 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 0615-7973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0801cbcc-figure-01 (Hydralazine Tabs 7973 1)

0801cbcc-figure-01 (Hydralazine Tabs 7973 1)
Chemical structure of Hydralazine Hydrochloride, showing the bicyclic ring with attached hydrazine and nitrogen groups, and an associated hydrochloride (HCl) molecule.*
FDA Label Image

Principal Display Panel (Hydralazine Tabs 7973 2)

Principal Display Panel (Hydralazine Tabs 7973 2)
Hydralazine Hydrochloride Tablets, USP 100 mg oral tablets, labeled for human prescription use by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes multiple barcodes, lots numbered 7973, with storage instructions to keep at controlled room temperature (20°-25°C). It indicates a quantity of 30 tablets and states 'For Institutional Use Only.' Manufactured by Hetero for Camber and packaged by Vangard in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.